How a streamlined CLD process can fast-track biologics to IND

How a complex but common carbohydrate could help add a new dimension to 3D-printed pills

New technologies offer cheaper modes of manufacture – here’s how and why the world’s less wealthy countries could seize the moment.

UICC CEO Cary Adams gives his insights into the challenges of getting cancer treatment to people in low- and middle-income countries.

Growth, expansion, and acquisitions in Germany are on the menu for this global testing and safety company – here’s why

Leaders at Artios explore the potential of expanding therapeutic opportunities in DDR beyond synthetic lethality

Applied correctly, data can do almost anything

Anti-vaccine activists are suing a number of prominent media outlets, including Reuters, the Washington Post, the BBC, and the Associated Press.

It’s a fact that the pharma industry is dominated by white men. What does this mean for people from different ethnic backgrounds?

From video games to climate change; looking back on a handful of articles from 2022.